We welcome the Medical University of South Carolina (MUSC) as new customer for CliniDeID and look forward to supporting their team and needs with clinical data de-identification.
To support research efforts aiming at COVID-19 and the SARS-CoV-2 virus, Clinacuity is offering FREE full licenses for CliniDeID® (on-premise version). Clinical data de-identification, as offered by CliniDeID, enables large scale research combining datasets from multiple different organizations, sharing patient data and analyzing it without having to obtain patient informed consent, all while preserving patient data privacy and confidentiality.
This special offer only applies to research focused on COVID-19 and license agreements established by May 31, 2020 (the research efforts involved can last longer than this period).
As presented yesterday (March 23, 2020) by Paul Heider (MUSC, Charleston, SC) at the AMIA Summits conference converted to a virtual event, CliniDeID allowed de-identifying clinical notes with significantly higher accuracy (recall and precision) than Amazon Comprehend Medical or NLM Scrubber. For example, CliniDeID found 99.89% of the mentions of patient names, Amazon Comprehend Medical found 92.91% and NLM Scrubber 89.61%.
The NIH National Institute for General Medical Sciences (NIGMS) has awarded a new technology transfer grant to Clinacuity to further develop CliniDeID® for highly accurate, robust and scalable clinical data de-identification. This large effort is realized in collaboration with the Medical University of South Carolina (MUSC) Translational Biomedical Informatics Center.
Clinacuity is pleased to announce that it has achieved compliance with the federally mandated standards of the Health Insurance Portability and Accountability Act (HIPAA) through the use of Compliancy Group’s proprietary HIPAA methodology, The Guard® compliance tracking software, and HIPAA Seal of Compliance®.
HIPAA is made up of a set of regulatory standards governing the security, privacy, and integrity of sensitive health care data, called protected health information (PHI). PHI is any demographic health care-related information that can be used to identify a patient. If vendors who service health care clients come into contact with PHI in any way, those vendors must be HIPAA compliant.
Clinacuity has completed Compliancy Group’s Six Stage Implementation Program, adhering to the necessary regulatory standards outlined in the HIPAA Privacy Rule, HIPAA Security Rule, HIPAA Breach Notification Rule, HIPAA Omnibus Rule, and HITECH. These standards have been heavily vetted against the letter of the law and meet federal NIST requirements. Clinacuity’s good faith effort toward HIPAA compliance through the use of The Guard has been verified by the HIPAA subject matter experts and Compliance Coaches at Compliancy Group.
The HIPAA Seal of Compliance is issued to organizations that have implemented an effective HIPAA compliance program through the use of The Guard, Compliancy Group’s proprietary compliance tracking solution.
Clinacuity has completed the Compliancy Group Implementation Program under the guidance of Compliancy Group’s team of expert Compliance Coaches®. The important intersection between HIPAA compliance and data security is often lost on IT providers working in the health care space. Clients are becoming more aware of the requirements of HIPAA compliance–and forward-thinking providers like Clinacuity choose the HIPAA Seal of Compliance to differentiate their services.
About Compliancy Group:
Compliancy Group simplifies HIPAA compliance so that health care professionals can confidently run their practice. The Guard™ is our simple, cost-effective, web-based solution. Users are guided by our team of expert Compliance Coaches™ to Achieve, Illustrate, and Maintain™ total HIPAA compliance. Visit https://www.compliancy-group.com or call 855.854.4722 to learn how simple compliance can be.
Clinacuity will be present at the upcoming HIMSS 2020 conference in Orlando (FL) March 9-13 2020.
Visit us at booth 530 to discover CliniDeID® and discuss how we can help you access richer, more detailed and more accurate clinical data for clinical research, ease research data sharing, protect patient data confidentiality and reduce financial risks and penalties for patient data leaks.
NLP development and evaluation requires tools to compare annotations, analyze differences, and compute accuracy metrics.
None of the few existing tools allows consuming the output of any NLP system, comparing it with reference annotations in any format (both with configuration), setting comparison rules, counting matches and computing accuracy metrics, visually displaying matching and erroneous annotations, changing the displayed information for analysis on the fly, exporting evaluation results, etc.
ETUDE (Evaluation Tool for Unstructured Data and Extractions) is a collaborative development by the MUSC TBIC (Paul Heider, for the engine) and by Clinacuity, Inc.
It offers the following functionalities:
- Import of annotations (system output and reference standard) in multiple configurable formats
- Drag-and-drop creation of evaluation configuration files (i.e., specification of annotation categories and attributes to match and compare)
- Customizable annotation comparison settings (base includes exact, partial, and fully-contained matches)
- Count and comparison of annotations, computing descriptive statistics, a confusion matrix of matches and mismatches, and computing accuracy metrics (recall, precision, F-measure)
- Show side-by-side reference and system annotations in the original document context with easy exploration of matches and errors
- Export of evaluation results in various configurable formats
Clinacuity was featured in the NCET2 Innovator Showcase at the Venture Houston 2018 conference (November 8-9, 2018).
Press release available at http://www.scra.org/media-center/new-sc-launch-client-companies-jan
Summerville, S.C. – SCRA announced the recent acceptance of five Client Companies into its entrepreneurial program, SC Launch. Client Companies receive mentoring and support services and may also be eligible for grants, matching funds and investments.
Clinacuity’s solutions extract critical information from patient electronic healthcare records. The data extracted provides clarity and efficiency to improve patient care as well as provides de-identified information to researchers that will enhance treatment outcomes. The company is developing two product prototypes with funding from the National Cancer Institute and the National Institute of General Medical Sciences with clinical impact evaluations by Hollings Cancer Center at the Medical University of South Carolina and the University of Utah.
Clinacuity has been selected to participate in the biennial NIH Commercialization Accelerator Program (CAP) for 2017-2018, an excellent opportunity for our company!
The CAP is designed to help NIH technology transfer funding awardees transition their SBIR/STTR developed products into the marketplace through a contract with Larta Inc.
It will provide companies with individualized assistance toward accomplishing their commercialization goals.